Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies
Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.
A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference
Anti-prion activity of an RNA aptamer and its structural basis
DNA mimicry by a high-affinity anti-NF-κB RNA aptamer
Bioactivity of anti-angiogenic ribozymes targeting Flt-1 and KDR mRNA
A longitudinal study of anti-RNA polymerase III antibody levels in systemic sclerosis
Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay
Bacteriophage Xp10 anti-termination factor p7 induces forward translocation by host RNA polymerase
Thorough validation of siRNA-induced cell death phenotypes defines new anti-apoptotic protein
Prevalence of hepatitis G virus RNA and anti-E2 in a Japanese haemodialysis population.
The anti-cancer drug camptothecin inhibits elongation but stimulates initiation of RNA polymerase II transcription
Identification of an anti-TB compound targeting the tyrosyl-tRNA synthetase
E43 Anti-Transfer RNA Synthetase Syndrome Presenting as Cryptogenic Organising Pneumonia
Non-inhibited miRNAs shape the cellular response to anti-miR
Anti-synthetase syndrome positive for anti-isoleucyl-tRNA synthetase antibodies: an unusual case overlapping with systemic sclerosis and Sjögren's syndrome
Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia
Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases
Show all results sharing this subject:
Single‐stranded RNA complementary to mRNA. See antisense RNA.
Oxford Dictionary of Biochemistry and Molecular Biology »
See all related items in Oxford Index »
Search for the text `anti-RNA' anywhere in Oxford Index »
Users without a subscription are not able to see the full content. Please,
or login to access all content.
Forgot your password?